|
YKT6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.30686605770825E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.87599999371224E-09 |
| Normal-vs-Stage2 |
4.415900E-02 |
| Normal-vs-Stage3 |
4.197000E-03 |
| Normal-vs-Stage4 |
6.177700E-02 |
| Stage1-vs-Stage2 |
7.361800E-01 |
| Stage1-vs-Stage3 |
9.491600E-01 |
| Stage1-vs-Stage4 |
9.593200E-01 |
| Stage2-vs-Stage3 |
8.262800E-01 |
| Stage2-vs-Stage4 |
8.123800E-01 |
| Stage3-vs-Stage4 |
9.355800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.63320484808582E-12 |
| Normal-vs-AfricanAmerican |
2.49270000000079E-05 |
| Normal-vs-Asian |
1.680170E-01 |
| Caucasian-vs-AfricanAmerican |
7.737600E-01 |
| Caucasian-vs-Asian |
7.599400E-01 |
| AfricanAmerican-vs-Asian |
7.059000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18216547662087E-12 |
| Normal-vs-Female |
2.38499999971609E-07 |
| Male-vs-Female |
7.957600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.795000E-03 |
| Normal-vs-Extreme_Weight |
5.37800000088851E-08 |
| Normal-vs-Obese |
2.95230000002533E-07 |
| Normal-vs-Extreme_Obese |
7.318200E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.631000E-01 |
| Normal_Weight-vs-Obese |
7.158400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.122600E-01 |
| Extreme_Weight-vs-Obese |
4.678200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.200000E-01 |
| Obese-vs-Extreme_Obese |
6.515000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.366500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.18829945883192E-10 |
| Normal-vs-Age(61-80Yrs) |
6.90869994546262E-09 |
| Normal-vs-Age(81-100Yrs) |
1.062820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.671200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.418580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.188600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.044800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.713800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.395600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11022302462516E-16 |
| Normal-VS-Type2 PRCC |
1.347750E-02 |
| Normal-VS-KIRP CIMP |
8.484200E-03 |
| Normal-VS-Unclassified PRCC |
6.219500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.80539999999586E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.887200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.075800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.087980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.037800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.506200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.319700E-03 |
| Normal-vs-N1 |
6.600200E-03 |
| Normal-vs-N2 |
1.464020E-01 |
| N0-vs-N1 |
3.659400E-01 |
| N0-vs-N2 |
3.148400E-01 |
| N1-vs-N2 |
6.237000E-01 |
|
|
